Roehrborn CG - Search Results

1

Prospective Monitoring and Adapting Strategies for Prevention of Infection Following Transrectal Prostate Procedures.

Woldu SL, Hutchinson RC, Singla N, Hornberger B, Roehrborn CG, Lotan Y. Woldu SL, et al. Among authors: roehrborn cg. Urol Pract. 2018 Mar;5(2):124-131. doi: 10.1016/j.urpr.2017.03.002. Epub 2017 Mar 18. Urol Pract. 2018. PMID: 29687052 Free PMC article.

2

Variability of repeated serum prostate-specific antigen (PSA) measurements within less than 90 days in a well-defined patient population.

Roehrborn CG, Pickens GJ, Carmody T 3rd. Roehrborn CG, et al. Urology. 1996 Jan;47(1):59-66. doi: 10.1016/s0090-4295(99)80383-5. Urology. 1996. PMID: 8560664

3

Diagnostic yield of repeated transrectal ultrasound-guided biopsies stratified by specific histopathologic diagnoses and prostate specific antigen levels.

Roehrborn CG, Pickens GJ, Sanders JS. Roehrborn CG, et al. Urology. 1996 Mar;47(3):347-52. doi: 10.1016/s0090-4295(99)80451-8. Urology. 1996. PMID: 8633400

4

Correlation between prostate size estimated by digital rectal examination and measured by transrectal ultrasound.

Roehrborn CG, Girman CJ, Rhodes T, Hanson KA, Collins GN, Sech SM, Jacobsen SJ, Garraway WM, Lieber MM. Roehrborn CG, et al. Urology. 1997 Apr;49(4):548-57. doi: 10.1016/s0090-4295(97)00031-9. Urology. 1997. PMID: 9111624 Clinical Trial.

5

Antimicrobial prophylaxis prior to shock wave lithotripsy in patients with sterile urine before treatment: a meta-analysis and cost-effectiveness analysis.

Pearle MS, Roehrborn CG. Pearle MS, et al. Among authors: roehrborn cg. Urology. 1997 May;49(5):679-86. doi: 10.1016/S0090-4295(96)00626-7. Urology. 1997. PMID: 9145970

6

Transurethral needle ablation for benign prostatic hyperplasia: 12-month results of a prospective, multicenter U.S. study.

Roehrborn CG, Issa MM, Bruskewitz RC, Naslund MJ, Oesterling JE, Perez-Marrero R, Shumaker BP, Narayan P. Roehrborn CG, et al. Urology. 1998 Mar;51(3):415-21. doi: 10.1016/s0090-4295(97)00682-1. Urology. 1998. PMID: 9510346 Clinical Trial.

7

Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia.

Roehrborn CG, Boyle P, Gould AL, Waldstreicher J. Roehrborn CG, et al. Urology. 1999 Mar;53(3):581-9. doi: 10.1016/s0090-4295(98)00655-4. Urology. 1999. PMID: 10096388

8

The effects of transurethral needle ablation and resection of the prostate on pressure flow urodynamic parameters: analysis of the United States randomized study.

Roehrborn CG, Burkhard FC, Bruskewitz RC, Issa MM, Perez-Marrero R, Naslund MJ, Shumaker BP. Roehrborn CG, et al. J Urol. 1999 Jul;162(1):92-7. doi: 10.1097/00005392-199907000-00023. J Urol. 1999. PMID: 10379748 Clinical Trial.

9

Have complication rates decreased after treatment for localized prostate cancer?

Thompson IM, Middleton RG, Optenberg SA, Austenfeld MS, Smalley SR, Cooner WH, Correa RJ Jr, Miller HC Jr, Oesterling JE, Resnick MI, Wasson JH, Roehrborn CG. Thompson IM, et al. Among authors: roehrborn cg. J Urol. 1999 Jul;162(1):107-12. doi: 10.1097/00005392-199907000-00026. J Urol. 1999. PMID: 10379751 Review.

10

Interexaminer reliability of transrectal ultrasound for estimating prostate volume.

Sech S, Montoya J, Girman CJ, Rhodes T, Roehrborn CG. Sech S, et al. Among authors: roehrborn cg. J Urol. 2001 Jul;166(1):125-9. J Urol. 2001. PMID: 11435838 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

532 results

Search Page

Filters